Cabozantinib in Men With Castration-Resistant Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01703065
Recruitment Status : Terminated (Closed 2017 for low accrual. Last data for primary outcome on 02Feb2015.)
First Posted : October 10, 2012
Last Update Posted : December 5, 2017
Prostate Cancer Foundation
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Celestia Higano, University of Washington

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : February 2, 2015
  Actual Study Completion Date : September 18, 2015
  Certification/Extension First Submitted : October 16, 2017